Portolan Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.18M | Buy |
1,163,400
+613,478
| +112% | +$3.26M | 0.39% | 75 |
|
|
2025
Q1 | $4.88M | Buy |
+549,922
| New | +$4.88M | 0.37% | 76 |
|
|
2024
Q4 | – | Sell |
-179,634
| Closed | -$4.92M | – | 156 |
|
|
2024
Q3 | $4.92M | Buy |
+179,634
| New | +$4.92M | 0.36% | 86 |
|
|
2019
Q2 | – | Sell |
-125,532
| Closed | -$4.17M | – | 92 |
|
|
2019
Q1 | $4.17M | Buy |
+125,532
| New | +$4.17M | 0.43% | 72 |
|
|
2016
Q4 | – | Sell |
-277,294
| Closed | -$5.71M | – | 131 |
|
|
2016
Q3 | $5.71M | Buy |
277,294
+93,729
| +51% | +$1.93M | 0.78% | 50 |
|
|
2016
Q2 | $5.62M | Sell |
183,565
-18,007
| -9% | -$551K | 0.81% | 46 |
|
|
2016
Q1 | $7.55M | Buy |
+201,572
| New | +$7.55M | 1.01% | 33 |
|
|
2015
Q2 | – | Sell |
-95,983
| Closed | -$3.4M | – | 124 |
|
|
2015
Q1 | $3.4M | Buy |
95,983
+20,360
| +27% | +$721K | 0.62% | 62 |
|
|
2014
Q4 | $2.58M | Buy |
+75,623
| New | +$2.58M | 0.52% | 77 |
|